ImmunityBio, Inc.IBRXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank83
3Y CAGR+12.4%
5Y CAGR+15.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+12.4%/yr
vs +30.5%/yr prior
5Y CAGR
+15.4%/yr
Recent deceleration
Acceleration
-18.1pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $145.66M | -13.7% |
| 2024 | $168.78M | +30.2% |
| 2023 | $129.62M | +26.2% |
| 2022 | $102.71M | -24.1% |
| 2021 | $135.26M | +89.7% |
| 2020 | $71.32M | +687.8% |
| 2019 | $9.05M | -74.5% |
| 2018 | $35.46M | -34.1% |
| 2017 | $53.82M | -43.0% |
| 2016 | $94.39M | - |